Poor correlation between acute phase reactants and intestinal involvement in patients with onset of Crohn's disease under treatment with an interleukin-6 inhibitor due to seronegative arthropathy
Gastroenterol Hepatol. 2016 Dec;39(10):670-672.
doi: 10.1016/j.gastrohep.2015.10.001.
Epub 2015 Nov 15.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Aparato Digestivo, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, España. Electronic address: Layozama@gmail.com.
- 2 Servicio de Reumatología, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, España.
- 3 Servicio de Aparato Digestivo, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, España.
No abstract available
MeSH terms
-
Acute-Phase Proteins / analysis*
-
Adrenal Cortex Hormones / therapeutic use
-
Adult
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Colonoscopy
-
Crohn Disease / blood
-
Crohn Disease / drug therapy
-
Crohn Disease / etiology*
-
Crohn Disease / pathology
-
Drug Substitution
-
Enteral Nutrition
-
Feces / chemistry
-
Female
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Interleukin-6 / antagonists & inhibitors*
-
Joint Diseases / drug therapy*
-
Joint Diseases / etiology
-
Leukocyte L1 Antigen Complex / analysis
Substances
-
Acute-Phase Proteins
-
Adrenal Cortex Hormones
-
Antibodies, Monoclonal, Humanized
-
IL6 protein, human
-
Immunosuppressive Agents
-
Interleukin-6
-
Leukocyte L1 Antigen Complex
-
tocilizumab